Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: NEUROLOGY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
abnormal movements in arms and legs
 
Major Surgical or Invasive Procedure:
none

 
Physical Exam:
General: Awake, cooperative, NAD.
HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in
oropharynx. syndromic facies
Neck: Supple, no carotid bruits appreciated. No nuchal rigidity
Pulmonary: Lungs CTA bilaterally without R/R/W
Cardiac: RRR, nl. S1S2, no M/R/G noted
Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or
organomegaly noted.
Extremities: No ___ edema.
Skin: no rashes or lesions noted.

Neurologic:
-Mental Status: Alert, oriented. States she is ___, not sure of
season. Can not relate history very much. Language is fluent 
with
intact repetition and comprehension. Normal prosody. There were
no paraphasic errors. Pt not able to name both high and low
frequency objects.   Speech was not dysarthric. Able to follow
both midline and appendicular commands.
-Cranial Nerves:
II, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI without
nystagmus. 
V: Facial sensation intact to light touch.
VII: No facial droop, facial musculature symmetric.
VIII: Hearing intact to finger-rub bilaterally.
IX, X: Palate elevates symmetrically.
XI: ___ strength in trapezii and SCM bilaterally.
XII: Tongue protrudes in midline.

-Motor: Normal bulk, tone throughout. No pronator drift
bilaterally.
No adventitious movements, such as tremor, noted. No asterixis
noted. Unable to participate in formal testing. No asymmetry,
antigravity in both arms, legs.

-Sensory: No deficits to light touch throughout. No extinction 
to
DSS.

-DTRs:
___ hyperreflexic 3

___ response was flexor bilaterally.

-Coordination: No intention tremor, no dysdiadochokinesia noted.
No dysmetria on FNF or HKS bilaterally.
 
Brief Hospital Course:
Ms. ___ is a ___ y/o woman w/ Down syndrome, early-onset 
Alzheimer disease, ___ syndrome (s/p b/l ECA-ICA bypass), 
h/o L brain stroke, and possible multifocal epilepsy; presenting 
w/ subacute intermittent myoclonic jerks w/ no LoC.
While there has been no change in gabapentin dosage, we believe 
that metabolism of the medication may have decreased with 
patient aging. This increased effective dose likely led to 
myoclonic jerks, a notable adverse effect of the medication.
In the hospital, we discontinued gabapentin (___). EEG was in 
place for several hours, showing no epileptiform activity or 
seizure.
Levetiracetam 500 mg was started as a replacement antiepileptic 
med.
Plan was discussed with Dr. ___, who is in 
agreement with plan.
Patient was discharged ___ to f/up as outpt w/ Dr. ___.
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
myoclonic jerks (iatrogenic)

 
Discharge Condition:
Mental Status: Clear and coherent (but limited by intellectual 
disability).
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,
  You were admitted for evaluation of myoclonic jerks.
  We believe that these jerks were a side effect of gabapentin, 
which we discontinued. For seizure prevention, we started you on 
levetiracetam.
  You should follow-up with your primary care and with Dr. 
___ in clinic.
 
Followup Instructions:
___